Caution Limited information is available
7, 2025 Journal of Obesity, A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity, May 10, 2024 KFF, Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford, Nov
It features a 13-amino-acid N-terminal extension plus an arginine substitution at position 3, modifications that markedly prolong half-life and reduce binding to IGF-binding proteins in laboratory models
Improved insulin sensitivity: For women with PCOS or metabolic syndrome, weight loss can improve insulin resistance, which may restore ovulatory cycles and regulate periods that were previously irregular
How to optimize results at each phase Knowing what to expect is valuable